57346-43-7 Usage
Description
5-MethoxyMethyluracil, also known as 5-methoxymethyl-2,4(1H,3H)-pyrimidinedione, is a chemical compound with the molecular formula C6H8N2O3. It is a derivative of uracil and belongs to the group of pyrimidine nucleobases.
Used in Pharmaceutical Industry:
5-MethoxyMethyluracil is used as an antiviral agent for its potential to inhibit the replication of certain viruses, including herpes simplex virus (HSV) and human cytomegalovirus (HCMV).
Used in Chronic Fatigue Syndrome Treatment:
5-MethoxyMethyluracil is used as an immune system enhancer for its potential use in treating chronic fatigue syndrome.
Used in Synthesis of Pharmaceutical Compounds:
5-MethoxyMethyluracil is used as a reactant in the synthesis of various pharmaceutical compounds.
Used in Over-the-Counter Health Supplements:
5-MethoxyMethyluracil can be found as an ingredient in some over-the-counter health supplements.
Check Digit Verification of cas no
The CAS Registry Mumber 57346-43-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,3,4 and 6 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 57346-43:
(7*5)+(6*7)+(5*3)+(4*4)+(3*6)+(2*4)+(1*3)=137
137 % 10 = 7
So 57346-43-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O3/c1-11-3-4-2-7-6(10)8-5(4)9/h2H,3H2,1H3,(H2,7,8,9,10)
57346-43-7Relevant articles and documents
MONOCYCLIC PYRIMIDINE/PYRIDINE COMPOUNDS AS INHIBITORS OF P97 COMPLEX
-
Page/Page column 126, (2015/06/25)
Monocyclic pyrimidine and pyridine compounds having a benzyl amine substituent at the 4 position and a 5:6 bicyclic heteroaryl substituent at the 2 position of the pyrimidine or pyridine ring as well as optional aliphatic, functional and/or aromatic components substituted at other positions of the ring are disclosed. These compounds are inhibitors of the AAA proteasome complex containing p97 and are effective medicinal agents for treatment of diseases associated with p97 bioactivity such as cancer.
Anodic decarboxylative oxidation of carboxymethyluracil and -thymine isomers
Kaminski, Jaroslaw,Pachulska, Maria,Stolarski, Ryszard,Kazimierczuk, Zygmunt
, p. 2609 - 2616 (2007/10/03)
The anodic oxidative decarboxylation of isomers of uracil and thymine acetic acids was studied. Electrolysis in methanolic or ethanolic solutions yielded respective alkoxymethyl derivatives via carbocationic intermediates. In acetic acid/sodium acetate medium, these were trapped by acetate, resulting in corresponding acetoxymethyl derivatives. Electrolysis in fully deuterated methanol or deuterated acetic acid, allow to obtain respective trideuterated compounds.
